497 related articles for article (PubMed ID: 19589728)
1. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory bowel disease: a model of chronic inflammation-induced cancer.
Yang GY; Taboada S; Liao J
Methods Mol Biol; 2009; 511():193-233. PubMed ID: 19347299
[TBL] [Abstract][Full Text] [Related]
3. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
Azer SA
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
Itzkowitz SH; Yio X
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
[TBL] [Abstract][Full Text] [Related]
5. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
6. Inflammation in sporadic colorectal cancer.
Moossavi S; Bishehsari F
Arch Iran Med; 2012 Mar; 15(3):166-70. PubMed ID: 22369306
[TBL] [Abstract][Full Text] [Related]
7. Endoscopy/surveillance in inflammatory bowel disease.
Ahmadi AA; Polyak S
Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
[TBL] [Abstract][Full Text] [Related]
8. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model.
Koelink PJ; Robanus-Maandag EC; Devilee P; Hommes DW; Lamers CB; Verspaget HW
Carcinogenesis; 2009 Jul; 30(7):1217-24. PubMed ID: 19420017
[TBL] [Abstract][Full Text] [Related]
10. Genetic ablation of Tnfalpha demonstrates no detectable suppressive effect on inflammation-related mouse colon tumorigenesis.
Sakai H; Yamada Y; Shimizu M; Saito K; Moriwaki H; Hara A
Chem Biol Interact; 2010 Mar; 184(3):423-30. PubMed ID: 20079348
[TBL] [Abstract][Full Text] [Related]
11. Potential avenues for immunotherapy of colitis-associated neoplasia.
Waldner MJ; Neurath MF
Immunotherapy; 2012 Apr; 4(4):397-405. PubMed ID: 22512634
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB in inflammatory bowel disease.
Atreya I; Atreya R; Neurath MF
J Intern Med; 2008 Jun; 263(6):591-6. PubMed ID: 18479258
[TBL] [Abstract][Full Text] [Related]
13. Role of Inflammation in the Development of Colorectal Cancer.
Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
[TBL] [Abstract][Full Text] [Related]
14. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model.
Matsumoto S; Hara T; Mitsuyama K; Yamamoto M; Tsuruta O; Sata M; Scheller J; Rose-John S; Kado S; Takada T
J Immunol; 2010 Feb; 184(3):1543-51. PubMed ID: 20042582
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications.
Goel GA; Kandiel A; Achkar JP; Lashner B
Am J Gastroenterol; 2011 Apr; 106(4):719-30. PubMed ID: 21386829
[TBL] [Abstract][Full Text] [Related]
17. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B
Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817
[TBL] [Abstract][Full Text] [Related]
19. [The role of cysteinyl leukotrienes in chronic inflammation and neoplasia of the intestine].
Broom OJ; Nielsen OH
Ugeskr Laeger; 2009 Jan; 171(4):243-6. PubMed ID: 19174041
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]